Ireland
--:--IST
Starting soon Not applicable

Dual-Task Training in Children With Spastic Diplegic Cerebral Palsy

NCT07870135 · tracked via the Priya Life Science Egypt tracker
Sponsor
Raneem Ahmad Mohammad Ashshi
Phase
Not applicable
Started
2026-11-01
Last updated
2026-10-13

Condition(s) studied

Spastic Diplegia Cerebral Palsy

Investigational drug(s) / intervention(s)

Dual-Task orientedTraditional Physical Therapy Program

Dual-Task oriented: Participants will perform dual-task oriented training consisting of motor and cognitive dual-task activities during gait and balance exercises. The training includes walking while performing concurrent motor tasks, such as holding or bouncing a ball, and cognitive tasks while walking. Task difficulty will be progressively increased according to the participant's ability.

Traditional Physical Therapy Program: Participants will receive a traditional physical therapy program including stretching exercises, standing and balance training, and walking exercises

Study summary

This randomized controlled trial aims to investigate the effect of dual-task oriented training on functional performance in children with spastic diplegic cerebral palsy. Participants will be randomly assigned to two groups. The experimental group will receive a designed physical therapy program combined with dual-task oriented training, while the control group will receive the designed physical therapy program only. The study will evaluate changes in gait and balance before and after the intervention. Gait performance will be assessed using spatiotemporal gait parameters, and functional balance will be assessed using the Pediatric Balance Scale.

Eligibility

Sex
ALL
Min age
4 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Children diagnosed with spastic diplegic cerebral palsy. * GMFCS levels I-III. * Aged 4-18 years. * Able to follow simple commands. * Modified Ashworth Scale score from 0 to +1. Exclusion Criteria: * Visual or hearing impairments. * Cardiovascular disease. * Fixed musculoskeletal deformities. * Orthopedic surgery within the previous 6 months. * Botulinum toxin injections within the previous 6 months. * History of uncontrolled seizures.

Primary outcome measure(s)

  • Change in Gait Velocity — Baseline and immediately after completion of the intervention
    Gait velocity will be assessed using Kinovea video analysis software and reported in meters per second (m/s).

Trial sites (1)

FacilityCityRegionStatus
kafrelsheikh University Cairo Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07870135 on ClinicalTrials.gov ↗ ← All trials in Egypt